Glaukos

$85.02
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.88 (-1.02%) Today

$0.00 (0.00%) As of 10:00 PM UTC after-hours

Why Robinhood?

You can buy or sell Glaukos and other stocks, options, and ETFs commission-free!

About GKOS

Glaukos Corporation, also called Glaukos, is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology.

CEO

Thomas William Burns

Employees

653

Headquarters

San Clemente, California

Founded

1998

Market Cap

3.76B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

425.99K

High Today

$86.35

Low Today

$84.84

Open Price

$86.35

Volume

202.69K

52 Week High

$99.00

52 Week Low

$31.50

Analyst Ratings

20%

of 10 ratings

Buy

20%

Hold

70%

Sell

10%

GKOS Earnings

-$0.76

-$0.51

-$0.25

$0.00

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Available May 5, After Hours